Press and reviewer resources
Verified product facts, current iOS and Android screenshots, founder information, brand assets, and independent reviewer access for Dosio.
Product facts verified August 3, 2026 · Press contact: dosio@sustainabel.com
Dosio
GLP-1 tracker for shots, pills, side effects, health metrics, and progress
Launched
November 2025
Platforms
iOS, iPadOS & Android
Localization
10 languages
Current media kit
Version 2.0.1
Product overview
Dosio is developed and published by Sustainabel. It launched in November 2025 and is available free on iOS, iPadOS, and Android, with optional Dosio Pro functionality.
1,125
users served
Early product usage verified July 14, 2026.
3,600+
logged health events
Including 1,213 doses, 1,983 health metrics, and 432 side-effect entries, verified July 14, 2026.
Approved descriptions
Editors may shorten this language while preserving the distinction between personal tracking and medical guidance.
Short description
Dosio is a free GLP-1 tracker app for iOS and Android that helps people organize injectable or oral medication routines. Users can log doses, reminders, injection sites, side effects, weight, health metrics, and progress, then export their records as CSV or a formatted Dosio Pro PDF. Dosio is a personal tracking tool, not a medical device.
Extended description
Dosio is a free GLP-1 tracker app designed to make oral and injectable medication routines easier to record and review. Available on iOS, iPadOS, and Android, it brings dose schedules, reminders, injection-site history, side effects, appetite, weight, nutrition, hydration, health metrics, progress photos, and calendar context into one place. Dose Cycle and estimated medication-level views help users understand where they are within the routine they entered, without offering dosing recommendations. Users can export their complete record as CSV at no cost or create a formatted Dosio Pro PDF when they want a more readable appointment summary. Apple Health and Health Connect integrations are read-only, and imported platform health data is displayed without being stored in Dosio’s database. Dosio is developed by Sustainabel and is available in ten languages. It is a personal health and wellness tracking tool—not a medical device—and does not provide medical advice, diagnosis, treatment, or individualized dosing guidance.
Current product imagery
English-language screenshots from Dosio 2.0.1. Full-resolution files are included in the media kit.
iOS
Today and next dose
Android
Today and next dose
iOS
Dose history
Android
PDF and CSV export
Founder
AJ Gerrits is the founder of Dosio and leads its product development through Sustainabel. He created Dosio to make the practical work around GLP-1 routines—recording doses, remembering context, and preparing for conversations—feel calmer and less fragmented.
AJ can comment on consumer health-app design, privacy-conscious tracking, cross-platform product development, and the differences between tracking weekly injections and daily oral routines. Medical questions should be directed to a qualified clinician.
Independent journalists, reviewers, and qualified editorial contributors can request two months of Dosio Pro at no cost for product evaluation.
No coverage, endorsement, positive review, or backlink is required. Please identify your publication or channel when requesting access.
Request reviewer accessDownloadable assets
ZIP · logos, facts, iOS and Android screenshots
DownloadPNG · 1024 × 1024
DownloadSVG · scalable vector
DownloadCurrent screenshots are also available for the ten supported languages.
Dosio is a personal health and wellness tracking tool. It is not a medical device and does not provide medical advice, diagnosis, treatment, or dosing recommendations.
